Database of patients with cardia cancer at Institut Paoli-Calmettes
Official title: Institut Paoli Calmettes Cardia Cancer Database
Run by Institut Paoli-Calmettes · NCT02869477 · Data updated 2026-11-12
This study is collecting information from patients with cardia cancer to help improve understanding and treatment for this type of cancer in the future.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 95 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Locations | 1 site (Marseille, Bouches-du Rhône) |
| Status | Recruiting |
| Started | January 2002 |
| Main results expected | January 2030 |
| Study ends | December 2030 |
| Registry record updated | August 17, 2016 |
| Trial ID | NCT02869477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with cardia cancer.
✕Probably not a fit
Patients who do not have a diagnosis of cardia cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects data from patients diagnosed with cardia cancer at the Institut Paoli-Calmettes. The aim is to create a comprehensive database that can be used for further analysis and understanding of this specific type of cancer. By gathering clinical information, treatment outcomes, and patient demographics, the study seeks to enhance knowledge and improve future care strategies for cardia cancer patients.
Why it matters
Potential benefit: If successful, this database could lead to improved treatment protocols and better patient outcomes for those diagnosed with cardia cancer.
How similar studies have gone: While this approach is primarily observational and may not have direct precedents, similar databases have been successful in enhancing understanding and treatment of various cancers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of cardia cancer Exclusion Criteria: \-
Where it's running
-
Institut Paoli-Calmettes
Marseille, Bouches-du Rhône, France Recruiting
Study contacts
- Study coordinator: Dominique Genre, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: 0033491223778
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Candonilimab with Fruquintinib and Paclitaxel Albumin-Bound as second-line treatment for advanced gastric cancer
This phase 2 trial tests whether adding candonilimab to fruquintinib and nab-paclitaxel helps people with advanced gastric or gastroesophageal junction cancer who progressed after first-line therapy.
-
TEAS after gastrectomy to aid recovery after laparoscopic stomach cancer surgery
A randomized trial tests whether transcutaneous electrical acupoint stimulation (TEAS) after laparoscopic gastrectomy helps people recover faster and with less pain compared with a sham treatment.
-
Maintenance therapy in metastatic gastric cancer: a multicenter look from Colombia
This study reviews medical records of adults with metastatic gastric cancer in Colombia to see how patients fare after starting maintenance therapy following initial chemotherapy.
-
Stomach-Partitioning Surgery to Help Block Obstruction in Advanced Stomach Cancer
This trial tests whether stomach-partitioning gastrojejunostomy helps people with unresectable, advanced stomach cancer better tolerate food after surgery than the standard approach.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
TEAS timing to aid recovery after stomach cancer surgery
This trial tests whether transcutaneous electrical acupoint stimulation (TEAS) given around surgery helps people recover faster after laparoscopic gastrectomy for gastric cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.